What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
John F. Thompson mostly deals with Melanoma, Particle physics, Nuclear physics, Large Hadron Collider and Surgery.
His Melanoma research is multidisciplinary, incorporating elements of Internal medicine, Biopsy, Pathology and Metastasis.
His Internal medicine research focuses on Oncology and how it connects with Immunotherapy.
His research in Pathology intersects with topics in Cancer and Cancer research.
His work carried out in the field of Large Hadron Collider brings together such families of science as Invariant mass, Parton and Muon.
His Surgery research incorporates themes from Lymphadenectomy and Hazard ratio.
His most cited work include:
- Final Version of 2009 AJCC Melanoma Staging and Classification (3479 citations)
- Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma (2311 citations)
- Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System (2015 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Melanoma, Surgery, Internal medicine, Particle physics and Nuclear physics.
John F. Thompson has included themes like Biopsy, Radiology, Lymph node and Pathology in his Melanoma study.
The various areas that John F. Thompson examines in his Biopsy study include Sentinel lymph node and Sentinel node.
The Surgery study combines topics in areas such as Lymphadenectomy and Metastasis.
John F. Thompson interconnects Gastroenterology and Oncology in the investigation of issues within Internal medicine.
His studies in Nuclear physics integrate themes in fields like Boson and Quantum chromodynamics.
He most often published in these fields:
- Melanoma (64.87%)
- Surgery (25.50%)
- Internal medicine (25.56%)
What were the highlights of his more recent work (between 2017-2021)?
- Melanoma (64.87%)
- Internal medicine (25.56%)
- Oncology (17.20%)
In recent papers he was focusing on the following fields of study:
John F. Thompson mainly investigates Melanoma, Internal medicine, Oncology, Radiology and Cutaneous melanoma.
His Melanoma research includes themes of Biopsy, Surgical oncology, Sentinel node and Lymph node.
The concepts of his Biopsy study are interwoven with issues in Sentinel lymph node, Metastasis and Nomogram.
In his research, Adjuvant therapy is intimately related to Systemic therapy, which falls under the overarching field of Oncology.
His Radiology research includes elements of Prospective cohort study, Lymphatic system, Lymphadenectomy and Lymph.
His Cutaneous melanoma research is multidisciplinary, relying on both Breslow Thickness, Germline and Confidence interval.
Between 2017 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention. (218 citations)
- Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy (132 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
John F. Thompson focuses on Melanoma, Internal medicine, Cancer research, Cutaneous melanoma and Cancer.
His Melanoma research incorporates elements of Immune system, Immunotherapy, Metastasis, Radiology and Surgical oncology.
His studies deal with areas such as Biopsy and Sentinel node as well as Metastasis.
His work in Radiology addresses issues such as Breslow Thickness, which are connected to fields such as Survival rate.
The study incorporates disciplines such as Gastroenterology and Oncology in addition to Internal medicine.
His research investigates the connection between Cutaneous melanoma and topics such as Nevus that intersect with issues in DNA Mutational Analysis, Superficial spreading melanoma, Nodular melanoma and Genome.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
